-
STOK Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Stoke Therapeutics (STOK)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 150.59 mm | 150.59 mm | 150.59 mm | 150.59 mm | 150.59 mm | 150.59 mm |
Cash burn (monthly) | 14.49 mm | 3.33 mm | 10.00 mm | 9.78 mm | 7.21 mm | 7.03 mm |
Cash used (since last report) | 58.30 mm | 13.40 mm | 40.25 mm | 39.34 mm | 29.00 mm | 28.27 mm |
Cash remaining | 92.28 mm | 137.18 mm | 110.34 mm | 111.25 mm | 121.59 mm | 122.31 mm |
Runway (months of cash) | 6.4 | 41.2 | 11.0 | 11.4 | 16.9 | 17.4 |
13F holders | Current |
---|---|
Total holders | 119 |
Opened positions | 24 |
Closed positions | 20 |
Increased positions | 38 |
Reduced positions | 36 |
13F shares | Current |
---|---|
Total value | 710.86 bn |
Total shares | 61.73 mm |
Total puts | 34.60 k |
Total calls | 6.60 k |
Total put/call ratio | 5.2 |
Largest owners | Shares | Value |
---|---|---|
Skorpios Trust | 8.91 mm | $109.46 bn |
BlackRock | 5.57 mm | $68.46 bn |
Lynx1 Capital Management | 5.19 mm | $63.75 bn |
Redmile | 4.71 mm | $57.93 bn |
RTW Investments | 4.65 mm | $57.18 bn |
Baker Bros. Advisors | 4.37 mm | $53.69 bn |
MS Morgan Stanley | 4.21 mm | $51.68 bn |
Cowen Financial Products | 3.72 mm | $19.58 mm |
Cowen And | 3.24 mm | $39.87 bn |
Vanguard | 2.76 mm | $33.91 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Dec 24 | Kaye Edward M. MD | Common Stock | Option exercise | Acquire M | No | No | 0.6 | 35,000 | 21.00 k | 96,885 |
30 Dec 24 | Kaye Edward M. MD | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.6 | 35,000 | 21.00 k | 567,801 |
23 Dec 24 | Skorpios Trust | Common Stock | Sell | Dispose S | Yes | No | 11.5 | 2,000,000 | 23.00 mm | 6,906,181 |
9 Dec 24 | Ticho Barry | Common Stock | Sell | Dispose S | No | No | 12.9913 | 2,586 | 33.60 k | 44,746 |
9 Dec 24 | Jonathan Allan | Common Stock | Sell | Dispose S | No | No | 12.9923 | 1,552 | 20.16 k | 21,476 |
9 Dec 24 | Jonathan Allan | Common Stock | Sell | Dispose S | No | Yes | 13.6878 | 12,114 | 165.81 k | 23,028 |
9 Dec 24 | Kaye Edward M. MD | Common Stock | Sell | Dispose S | No | No | 12.9912 | 6,786 | 88.16 k | 61,885 |